Friday, May 1, 2026

Kia and Motability Launch Wheelchair-Accessible Electric Van in Push for Inclusive Transit

Kia introduces the wheelchair-accessible PV5 WAV in the UK, enhancing mobility for individuals with disabilities through innovative design.

US On The Clock: North Korea’s Nuclear Arsenal is Now Permanent, Ally Begs Trump For APEC Summit

Trump's upcoming APEC visit prompts diplomatic moves by North and South Korea, focusing on dialogue and North's nuclear capabilities.

Kim’s Yachts Spotted: Is North Korea Prepping for a Coastal Grand Opening?

Increased ship activity at Wonsan Port signals preparations for the June opening of North Korea's Kalma Coastal Tourist Zone.

Tag: disease

Daewoong Pharmaceutical and Primind’s Strategic Investment in American Biotech General Proximity

Daewoong Pharmaceutical invests in biotech firms to enhance drug development using Induced Proximity technology and expand globally.

Dengue Cases Surge in Vietnam, Warning Issued That Infections Will Continue to Rise

Dengue fever cases in Vietnam are surging, exceeding 30,000 in Q1 2023, prompting health warnings for travelers.

RSV Prevention: How New Antibody Treatment Can Save Infants from Severe Infections

RSV poses severe risks to infants; preventive antibodies offer protection, but costs are a concern. Policymakers are urged to adapt.

Celltrion Launches New Autoimmune Drug Avtozma in Japan

Celltrion launches Avtozma for autoimmune diseases in Japan, expanding its product portfolio and strengthening market presence.

Celltrion’s Steqeyma IV Approval: What This Means for Celltrion’s Growth in Japan’s Autoimmune Drug Market

Celltrion's Steqeyma IV formulation gains approval in Japan, expanding treatment for Crohn's disease and enhancing market competitiveness.

Celltrion sees prescription growth for key products in Europe, raises expectations for high-margin new drugs

Celltrion's cancer and autoimmune disease treatments are achieving stable growth in Europe, expanding their market influence.

SCL Healthcare secures patent for technology predicting metabolic syndrome using 3cc of blood

SCL Healthcare has patented a DNA methylation technology to predict metabolic syndrome risk, enhancing disease diagnosis from blood samples.

Neurophet Unveils AI-Powered Alzheimer’s Treatment Software at ITEM 2026 in Japan

Neurophet showcases AI-driven brain disease tech at ITEM 2026 in Japan, partnering with Hokuyaku Takeyama to expand market reach.

Unlocking the Future of Health: How Myokines Could Revolutionize Diabetes Management in 2026

HLB Life Care signs MOU to research myokines, aiming for innovations in health and functional foods with a focus on diabetes and aging.

Experts Warn Untreated Gum Disease Linked to Bad Breath and Tooth Damage

Persistent bad breath may indicate gum disease, requiring treatment like scaling and proper hygiene for improvement.

Is A Breakthrough For Thyroid Eye Disease Still Out Of Reach?

HanAll Biopharma's Phase 3 trial of batoclimab for Thyroid Eye Disease failed to show statistical significance, but safety profiles remain consistent.

AI in Healthcare: How South Korea’s 90 Million KRW Initiative is Transforming Chronic Disease Management

The Ministry of Health and Welfare launches a 90 billion KRW AI project to enhance chronic disease care across healthcare sectors.

“Lowering Cholesterol Beyond Current Targets Helps Prevent Cardiovascular Disease”

Lowering LDL cholesterol targets to below 55 mg/dL significantly reduces cardiovascular events in high-risk patients, study shows.

Emergency Surgery Saves Beagle: How Quick Action Restored Mobility After Cervical Disc Disease

A Beagle regained mobility after emergency surgery for cervical disc disease, highlighting the need for quick diagnosis and treatment.

Top News

- Our Sponsors Ad -

Follow us